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ABSTRACT
Objectives: We evaluated the efficacy of Microporous
Polysaccharide Hemospheres (MPH) for parenchymal he-
mostasis during laparoscopic partial nephrectomy (LPN)
in the porcine model.
Methods: Six female farm pigs underwent a transperito-
neal right lower-pole LPN during occlusion of the renal
hilum. Renal parenchyma was excised using cold Endos-
hears. MPH was applied to the defect and the hilar clamp
released. Animals were kept alive for one week. Before
sacrifice, left LPN was similarly performed using MPH.
Study variables included blood loss, number of MPH ap-
plications, hilar clamp time, hemostasis time, periopera-
tive complications, and abnormalities noted at sacrifice.
Results: Hemostasis was achieved in all kidneys solely by
using MPH. The average excised specimen represented
5.6% (range, 3.6 to 8.5) of renal weight. Mean hilar clamp
and hemostatic times were 12.8 minutes (range, 6 to 18)
and 2 minutes (range, 1 to 3), respectively. Hemostasis
occurred after one MPH application in 8 kidneys (67%). In
3 kidneys, additional MPH powder was required to treat
minor residual bleeding. In the remaining kidney, a sec-
ond standard MPH application was required for hemosta-
sis. No operative complications were encountered. No
hematomas or residual MPH was found at necropsy; how-
ever, small urinomas were found in 2 of 6 kidneys.
Conclusions: In the experimental porcine model, this
initial study suggests that MPH provides effective paren-
chymal hemostasis during laparoscopic resection of an
exophytic kidney lesion.
Key Words: Laparoscopy, Nephron-sparing surgery, Mi-
croporous Polysaccharide Hemospheres, Hemostasis, Re-
nal tumor.
INTRODUCTION
Hemostasis remains one of the most important technical
concerns associated with laparoscopic partial nephrec-
tomy (LPN). Controlling hemostasis during LPN can effec-
tively be performed by using bolsters and sutures in a
similar fashion as in open partial nephrectomy; however,
this technique can be time-consuming and challenging.1
Several hemostatic agents and technical adjuncts have
been evaluated in an attempt to simplify LPN, yet an
optimal alternative approach has not been realized.2–9
Microporous Polysaccharide Hemospheres (MPH,
Medafor Pharmaceutical Inc., Minneapolis, MN, USA) are
made entirely from purified plant starch10 that activates
the clotting cascade via a unique mechanism that hyper-
concentrates platelets and coagulation proteins.
Previously, a randomized study comparing MPH versus
conventional surgical techniques confirmed the efficacy of
this new hemostatic agent in achieving rapid and durable
hemostasis during open partial nephrectomy in the por-
cine model.10 However, the technical issues of laparo-
scopic cases present greater challenges in achieving he-
mostasis than in open cases, mainly in applying the agent
accurately and whether the agent will be able to stop
bleeding without the benefit of open techniques (ie, ap-
plying pressure). Thus, the goal of this pilot study is to
evaluate the feasibility of MPH for controlling parenchy-
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SCIENTIFIC PAPERmal bleeding during partial nephrectomy in a laparo-
scopic environment.
METHODS
After approval of the study protocol by the Institutional
Animal Care and Use Committee, laparoscopic transperi-
toneal lower-pole partial nephrectomies were performed
in 8 Yorkshire white female pigs weighing 32.1 kg to 40
kg. Following development and refinement of the laparo-
scopic MPH application technique on the initial 2 animals,
6 pigs underwent our experimental protocol.
Following induction of general anesthesia, right-sided
LPN was performed using a standard 4-port transperito-
neal approach in a flank position. The peritoneal cavity
was insufflated to 15 mm Hg. After mobilization of the
kidney, the renal artery and vein were occluded with a
laparoscopic bulldog clamp. Renal parenchyma from the
inferior pole of the kidney was then excised using cold
Endoshears. The defect was circular in shape, 2 cm in
diameter, and 1cm in depth, thereby simulating the exci-
sion of a small exophytic renal mass.
Two grams of MPH were applied directly to the wound
surface using a custom laparoscopic applicator (Figures 1
and 2), taking care to keep the resection bed dry. Fol-
lowing MPH application, the vascular clamp was imme-
diately removed and pneumoperitoneum at 15mm Hg
was maintained for 3 minutes. If hemostasis was achieved
after 3 minutes, the pneumoperitoneum was released.
Every 10 minutes thereafter, intraperitoneal pressure was
reinstated to 15 mm Hg to completely visualize the resec-
tion bed for bleeding. This observation period of periodic
insufflation lasted for approximately 30 minutes following
initial MPH application. If major rebleeding occurred, an-
other standard MPH application (2.0 grams) was per-
formed in the same manner. In case of mild residual
bleeding, additional MPH (1.0 gram) was applied to the
oozing area without reclamping. If more than 2 total MPH
applications were required, the attempt was considered a
failure. At the end of the observation period, the renal
specimen was removed through an existing port site, and
the posterior peritoneum was closed. After surgery, the
animals were observed twice daily to monitor their gen-
eral well being and for any evidence of surgical compli-
cations.
One week later, each pig underwent the same procedure
on the contralateral kidney. The right kidney was also
examined in situ for evidence of delayed bleeding, hema-
toma, and adverse treatment effects to associated tissues.
Each animal was then sacrificed and both kidneys re-
moved. The right kidneys were used as a chronic phase
cohort to study pathologic changes after one week of
healing.
MPH efficacy was evaluated using the following variables:
blood loss (quantitated from the suction canister), number
of required MPH applications, hilar clamp time, hemosta-
sis time, resected and remnant renal weights, periopera-
tive complications, and presence of residual MPH on right
(chronic phase) kidneys. Hilar clamp time was defined as
the duration of renal artery and renal vein occlusion dur-
ing LPN. Hemostatic time was defined as the time needed
to achieve hemostasis with the first MPH application after
the bulldog clamp had been removed. For animals requir-
ing additional MPH applications, data on hemostatic time
were not recorded and therefore were excluded from the
final data analysis. The presence of residual MPH on right
kidneys was evaluated grossly and histologically with he-
matoxylin and eosin staining performed on paraffin-em-
bedded sections containing the resection edge and neigh-
boring renal parenchyma. All data were summarized using
descriptive statistics and performed with JMP4 software
(SAS Institute Inc., Cary, NC, USA).
RESULTS
Successful hemostasis was achieved in all 12 kidneys
solely by using MPH (Table 1). Hemostasis was attained
after one MPH application in 8 of 12 kidneys (67%). In 3
treated kidneys, a small amount of additional MPH (1.0
Figure 1. Laparoscopic microporous polysaccharide hemo-
spheres applicator loaded on the microporous polysaccharide
hemospheres custom applicator.
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remaining kidney, an additional standard 2.0-gram MPH
application was required to control residual central bleed-
ing with an overall 50-mL blood loss. Once complete
hemostasis had been achieved, no acute rebleeding was
noted for any kidney during the 30-minute observation
period.
Aside from the one LPN associated with a 50-mL blood
loss, remaining LPN procedures were associated with neg-
ligible blood loss. No intraoperative complications were
encountered, nor did gross violations of the collecting
system occur.
After one week of follow-up, no gross residual MPH was
found at necropsy among the chronic treatment kidneys.
Likewise, no evidence of MPH was found microscopically
at the wound surface (Figure 3). In 2 of 6 (33%) chronic
phase kidneys, however, small urinomas (each 2c mi n
greatest diameter) were found at necropsy, and these
represented the only postoperative complications in the
protocol. In each case, the urinoma was located in a
retroperitoneal position, and the animal was entirely
asymptomatic before sacrifice.
DISCUSSION
Effective parenchymal hemostasis remains an ongoing
technical concern with LPN.1–9 Although LPN techniques
that duplicate open nephron-sparing surgery have been
Figure 2. Macroscopic appearance of exposed renal parenchyma during (A) and 30 minutes after (B) the microporous polysaccharide
hemospheres application.
Table 1.
Study Variables (N  12 Kidneys)
Mean Range
Hilar clamp time (min) 12.8 6–18
Hemostatic time (min) 2 1–3
Specimen weight (g) 5.84 3.4–10.3
Remnant kidney weight (g) 96.7 77.7–111.4
% Resected kidney 5.6 3.6–8.5
Figure 3. Hematoxylin and Eosin staining showing no evidence
of residual microporous polysaccharide hemospheres at the re-
section zone one week after laparoscopic partial nephrectomy
(magnification 400x).
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limitation.1 Various alternative surgical techniques, de-
vices, and topical hemostatic agents have been proposed,
yet none have emerged as the optimal treatment for
LPN.2–9 On-going concerns regarding topical hemostatic
agents have centered around ease of use, preparation
time, the potential for viral transmission, biological inert-
ness, and cost.
MPH has successfully been applied in a clinical setting for
Mohs microsurgery.11 However, its efficacy has not yet
been proven in a minimally invasive setting. Advantages
of MPH include single-step application with no premix-
ing, no risk of viral transmission, low cost, and its flexi-
bility in delivery (either as a powder, a spray, or molded
into a solid form). However, as emphasized by Tan et al,11
MPH must be applied accurately and evenly to the bleed-
ing area, and time is needed for the blood clot to form.
Encouraging results were observed with MPH during LPN
in this pilot evaluation. Using the custom laparoscopic
applicator, MPH was easily applied onto the resected
kidney surface. Although we used a 12-mm trocar for
delivery of MPH, subsequent applicators can be used
through 5-mm through 12-mm trocars. Intraabdominal
pressure generated by the 15mm Hg of the pneumoperi-
toneum was sufficient to sustain contact between MPH
and the resected renal tissue, and direct pressure of the
applicator on the resection zone was not required. In two
thirds of the partially resected kidneys, almost immediate
hemostasis was achieved and maintained following reper-
fusion after one application.
MPH appeared to work best when applied to a dry field
and then exposed to blood. Due to the unique molecular
properties of MPH, it is important that the vessels are
unclamped after its application because the presence of
blood is required to activate the MPH and promote sub-
sequent clotting. In one case during the study, an addi-
tional 2-gram MPH application was needed to stop bleed-
ing in the central portion of the renal parenchyma. For this
secondary application, it was necessary to first remove the
residual MPH with saline so that the new MPH powder
would come in contact with fresh blood. The cause of the
bleeding was unknown, because the technical aspects of
this experiment were no different than those of the other
experiments in the protocol. During 3 other LPN proce-
dures in the study, minor oozing continued after the initial
MPH application. These instances could possibly be ex-
plained by insufficient or inappropriate wound coverage
with MPH using the laparoscopic applicator. In all of these
cases of minimal on-going bleeding, adding more MPH
powder to the wound easily resulted in complete hemo-
stasis.
While MPH did provide excellent parenchymal hemosta-
sis, additional study is needed to determine whether MPH
can seal collecting system violations. In 2 of 6 chronic
treatment kidneys, an asymptomatic small urinoma less
than 2cm in diameter was noted at necropsy. Clinically,
because many small renal tumors treated laparoscopically
are exophytic and because one may expect the collecting
system to be away from the resection site, the issue of
collecting system sealing with MPH may be of lesser
significance.
A number of limitations are associated with our study.
Because it was designed only for feasibility, the current
study lacked a control arm. Thus, any comparisons with
open techniques should be made with caution. The
method of measuring the blood loss was somewhat im-
precise because not all blood loss could be reliably col-
lected via the suction irrigator. In fact, in all but one case,
the bleeding was controlled so rapidly with MPH that we
could not quantify the blood loss with our suction device.
Lastly, one could argue that the percentage of excised
kidney tissue was small. However, for exophytic tumors
that we believe are amenable to LPN, a small percentage
of normal renal parenchyma is typically resected, and our
study was purposefully designed to answer the issue of
MPH efficacy in this specific clinical situation. Additional
experimentation is required to evaluate how deep the
renal parenchyma can be cut before uncontrollable bleed-
ing occurs.
CONCLUSION
In the experimental porcine model, this initial study sug-
gests that MPH provides effective parenchymal hemosta-
sis during laparoscopic resection of an exophytic kidney
lesion.
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